Ireland· IE-PA-PPA1463/066/008
Lamictal 50 mg tablets
A lamotrigine product containing lamotrigine, registered in Ireland by IMED Healthcare Ltd.,. The same ATC class is registered in 18 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Lamotrigine is registered in 18 of 19 countries.
Countries holding a registration under ATC N03AX09 (lamotrigine), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 10 of them publish a price we can compare per daily dose
Lamotrigine · ATC N03AX09
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of lamotrigine costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), the median price runs from $0.14 in United States to $4.21 in Switzerland — a ×30 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Lamotrigine · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$4.21
- IT Italy$2.00
- FR France$1.69
- US United States$0.14 (acquisition cost)
The record
At a glance
HPRA (Ireland)- Active substance
- Lamotrigine
- Manufacturer
- IMED Healthcare Ltd.,
- Country
- Ireland (IE)
- ATC code
- N03AX09
- ATC class
- Lamotrigine
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPPA1463/066/008
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
248 interactions on record for lamotrigine.
Graded by severity as the source publishes them — 68 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lamotrigine · interactions on record
248 records
- 68 moderate
- 9 minor
- 129 info
Most severe, free to view
- MetoclopramideA03FA01moderate
- DiphenhydraminA04AB05moderate
- DronabinolA04AD10moderate
- NabiloneA04AD11moderate
42 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N03AX09
Lamotrigine, as other registers publish it.
- CanadaAG-LAMOTRIGINEANGITA PHARMA INC.
- CanadaAG-LAMOTRIGINEANGITA PHARMA INC.
- CanadaAG-LAMOTRIGINEANGITA PHARMA INC.
- ItalyAMALESSAUROBINDO PHARMA ITALIA S.R.L.
- ItalyAMALESSAUROBINDO PHARMA ITALIA S.R.L.
- ItalyAMALESSAUROBINDO PHARMA ITALIA S.R.L.
- ItalyAMALESSAUROBINDO PHARMA ITALIA S.R.L.
- CanadaAPO-LAMOTRIGINEAPOTEX INC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6396e5fa-cd42-4edf-859a-516255ee9dbb GET /v1/drugs/6396e5fa-cd42-4edf-859a-516255ee9dbb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"N03AX09"
],
"strength": null,
"pa_number": "PPA1463/066/008",
"substances": [
"Lamotrigine"
],
"legal_basis": "Parallel importation notified in accordance with Article 76(3) of Directive 2001/83/EC",
"market_info": "Unknown",
"authorised_at": "23/04/2021",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about lamotrigine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.